Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 16:10:360.
doi: 10.3389/fphar.2019.00360. eCollection 2019.

Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon

Affiliations

Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon

Barbara Ruaro et al. Front Pharmacol. .

Abstract

Objectives: Raynaud's phenomenon (RP) is characterized by intense vasospasm of the digital arteries that causes characteristic color changes in fingers. There are two main types of RP: Primary RP (PRP) and Secondary RP (SRP). PRP is a benign condition. Whilst SRP is associated with several connective tissue diseases (CTD), in particular systemic sclerosis (SSc). The objectives of this report were: to present a short review on morphological (nailfold videocapillaroscopy, NVC) and functional techniques (laser tools and thermography) that allow for a correct diagnosis and treatment of RP and to investigate blood perfusion (BP) by laser speckle contrast analysis (LASCA) in different skin areas of hands and face in PRP, SRP to SSc, and healthy subjects (CNT). Methods: 31 PRP patients (LeRoy criteria), 70 SRP to SSc (ACR/EULAR criteria) and 68 CNT were enrolled. BP was assessed by LASCA at the level different areas of hands and face. NVC was performed to distinguish between PRP and SRP, and to detect the proper pattern of nailfold microangiopathy in SSc patients. Results: Both PRP and SRP showed a statistically significant lower BP than CNT at the level of fingertips (p < 0.0001), periungual (p < 0.0001), palmar aspect of 3rd finger (p < 0.0001), and palm areas (p < 0.0001). Moreover, BP was significantly lower in PRP than in SRP to SSc with the "Early" pattern of microangiopathy in the same areas as above (p < 0.04). Conclusion: By considering a small cohort of patients, BP of hands was found lower in PRP than in SSc patients with the "Early" NVC pattern of microangiopathy.

Keywords: Raynaud’s phenomenon; laser techniques; microvascular damage; nailfold videocapillaroscopy; peripheral blood perfusion; systemic sclerosis.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Laser Speckle Contrast Analysis (LASCA) images of secondary Raynaud’s phenomenon (RP) to systemic sclerosis, in a patient with a “Late” pattern of scleroderma microangiopathy (A), primary RP (B) and a healthy subject (C), showing the regions of interest (ROI - white circles) created at the level of dorsum and palm of the hand, dorsal and palmar aspect of the 3rd finger, periungual areas and fingertips to evaluate blood perfusion. Color code: blue corresponds to a low BP, yellow an intermediate BP and red a higher BP. Noteworthy is the fact that subjects with a late pattern have a prevalence of blue, indicating a low perfusion level.

References

    1. Aschwanden M., Daikeler T., Jaeger K. A., Thalhammer C., Gratwohl A., Matucci-Cerinic M., et al. (2008). Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed tissue disease. Ann. Rheum. Dis. 67 1057–1059. 10.1136/ard.2007.082008 - DOI - PubMed
    1. Avouac J., Fransen J., Walker U. A., Riccieri V., Smith V., Muller C., et al. (2011). Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a delphi consensus study from EULAR scleroderma trials and research group. Ann. Rheum. Dis. 70 476–481. 10.1136/ard.2010.136929 - DOI - PubMed
    1. Bernero E., Sulli A., Ferrari G., Ravera F., Pizzorni C., Ruaro B., et al. (2013). Prospective capillaroscopy-based study on transition from primary to secondary Raynaud’s phenomenon: preliminary results. Reumatismo 65 186–191. 10.4081/reumatismo.2013.186 - DOI - PubMed
    1. Block J. A., Sequeira W. (2001). Raynaud’s phenomenon. Lancet 357 2042–2048. 10.1016/S0140-6736(00)05118-7 - DOI - PubMed
    1. Burmester G. R., Bijlsma J. W. J., Cutolo M., McInnes I. B. (2017). Managing rheumatic and musculoskeletal diseases - past, present and future. Nat. Rev. Rheumatol. 13 443–448. 10.1038/nrrheum.2017.95 - DOI - PubMed